Arvinas (NASDAQ:ARVN) reported quarterly losses of $(1.10) per share which missed the analyst consensus estimate of $(0.55) by 98.92 percent. This is a 74.6 percent decrease over losses of $(0.63) per share from the same period last year. The company reported quarterly sales of $9.500 million which missed the analyst consensus estimate of $34.879 million by 72.76 percent. This is a 83.95 percent decrease over sales of $59.200 million the same period last year.